36 related articles for article (PubMed ID: 38520825)
1. Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.
Miller SJ; Sly JR; Rolfo C; Mack P; Villanueva A; Mazor M; Weber E; Lin JJ; Smith CB; Taioli E
Health Aff Sch; 2024 May; 2(5):qxae039. PubMed ID: 38783890
[TBL] [Abstract][Full Text] [Related]
2. Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.
Lange JM; Gogebakan KC; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):830-837. PubMed ID: 38506751
[TBL] [Abstract][Full Text] [Related]
3. Multi-year clinical outcomes of cancers diagnosed following detection by a blood-based multi-cancer early detection (MCED) test.
Buchanan AH; Lennon AM; Choudhry OA; Elias PZ; Rego SP; Sadler JR; Roberta J; Zhang Y; Flake DD; Salvati ZM; Wagner ES; Fishman EK; Papadopoulos N; Beer TM
Cancer Prev Res (Phila); 2024 May; ():. PubMed ID: 38819783
[TBL] [Abstract][Full Text] [Related]
4. Primary care patient interests in joining a planned multi-cancer early detection clinical trial.
Myers RE; Hallman MH; Shimada A; DiCarlo MA; Davis KV; Leach WT; Chambers CV
Cancer Med; 2024 May; 13(10):e7312. PubMed ID: 38785202
[TBL] [Abstract][Full Text] [Related]
5. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
6. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
[TBL] [Abstract][Full Text] [Related]
7. Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening.
Chambers CV; Leach WT; Davis K; Myers RE
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138900
[TBL] [Abstract][Full Text] [Related]
8. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
9. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
Schmeising-Barnes N; Waller J; Marlow LAV
Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
[TBL] [Abstract][Full Text] [Related]
10. Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.
Brito-Rocha T; Constâncio V; Henrique R; Jerónimo C
Cells; 2023 Mar; 12(6):. PubMed ID: 36980276
[TBL] [Abstract][Full Text] [Related]
11. Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection.
Guerra CE; Sharma PV; Castillo BS
Annu Rev Med; 2024 Jan; 75():67-81. PubMed ID: 37729031
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
